Follow The Filings

HTFL Heartflow

Heartflow earnings company data as of 4:47 AM ET 10/22

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -0.18 —
Rev — $64.1M —

Insider trades

Open-market buys and sales by HTFL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HTFL insider trades
  • $1.1M bought by 1 insider
  • $115M sold by 1 insider outside a trading plan
  • $25M sold by 4 insiders under 10b5-1 plans
  1. John C.m. Farquhar CEO
    Planned sale
    $1.9M 38,900 shares at $49.57 12% of stake
    Traded Oct 12 Filed Oct 14
  2. Campbell Rogers Chief Medical Officer
    Planned sale
    $987K 19,682 shares at $50.15 20% of stake
    Traded Sep 18 Filed Sep 21
  3. Vikram Verghese CFO
    Planned sale
    $1.2M 24,345 shares at $50.55 14% of stake
    Traded Sep 17–18 Filed Sep 18
  4. Vikram Verghese CFO
    Planned sale
    $1.8M 34,975 shares at $50.08 16% of stake
    Traded Sep 11–15 Filed Sep 15
  5. John C.m. Farquhar CEO
    Planned sale
    $1.8M 38,900 shares at $46.78 11% of stake
    Traded Sep 10–11 Filed Sep 14
  6. Vikram Verghese CFO
    Planned sale
    $332K 6,640 shares at $50.03 3% of stake
    Traded Sep 8 Filed Sep 10
  7. Vikram Verghese CFO
    Planned sale
    $1.7M 33,416 shares at $49.85 13% of stake
    Traded Sep 2–3 Filed Sep 4
  8. John C.m. Farquhar CEO
    Planned sale
    $1.4M 27,230 shares at $50.00 7% of stake
    Traded Aug 21 Filed Aug 25
  9. John C.m. Farquhar CEO
    Planned sale
    $1.5M 32,676 shares at $45.00 7.8% of stake
    Traded Aug 18 Filed Aug 20
  10. Campbell Rogers Chief Medical Officer
    Planned sale
    $380K 9,219 shares at $41.23 9.6% of stake
    Traded Aug 17 Filed Aug 19
  11. John C.m. Farquhar CEO
    Planned sale
    $608K 15,560 shares at $39.06 3.6% of stake
    Traded Aug 14 Filed Aug 18
  12. John C.m. Farquhar CEO
    Planned sale
    $639K 22,562 shares at $28.31 4.9% of stake
    Traded Aug 10 Filed Aug 12
  13. Campbell Rogers Chief Medical Officer
    Planned sale
    $237K 9,219 shares at $25.72 9.4% of stake
    Traded Jul 15 Filed Jul 17
  14. John C.m. Farquhar CEO
    Planned sale
    $626K 22,562 shares at $27.75 4.9% of stake
    Traded Jul 10 Filed Jul 13
  15. John C.m. Farquhar CEO
    Planned sale
    $1.4M 38,900 shares at $35.00 7.8% of stake
    Traded Jun 24 Filed Jun 26

Also filed in the last 12 months, not counted as buying or selling: 28 option exercises, 24 share withholdings for taxes, 7 stock grants, and 2 other transactions.

SEC filings

Recent issuer filings from EDGAR, 7 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 5.07

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.